Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Oxycodone hydrochloride/naloxone hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oxycodone 10mg / Naloxone 5mg modified-release tablets
0407020AFAAAAAA
|
Oxycodone hydrochloride/naloxone hydrochloride | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1,948 |
|
Oxycodone 20mg / Naloxone 10mg modified-release tablets
0407020AFAAABAB
|
Oxycodone hydrochloride/naloxone hydrochloride | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1,522 |
|
Oxycodone 5mg / Naloxone 2.5mg modified-release tablets
0407020AFAAACAC
|
Oxycodone hydrochloride/naloxone hydrochloride | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1,206 |
|
Oxycodone 40mg / Naloxone 20mg modified-release tablets
0407020AFAAADAD
|
Oxycodone hydrochloride/naloxone hydrochloride | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 532 |
|
Oxycodone 40mg/5ml / Naloxone 20mg/5ml oral suspension
0407020AFAAAEAE
|
Oxycodone hydrochloride/naloxone hydrochloride | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.